Results

1–10 of 21 results for Anti-VEGF treatment

The Mystery of Subfoveal Nodule in Coats Disease
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2023
Defining a 'Strong' and 'Weak' Response to Anti-VEGF Treatment CI-DME: Retrospective Analysis of 3 DRCR Retina Network Clinical Trials
Sharon D. Solomon, MD
Annual Meeting Talks
2023
Long-Term Outcomes of Prophylactic Anti-VEGF Treatment in Patients Treated With Proton Irradiation for Choroidal Melanoma
On Demand Cases, Courses, and Papers
2022
Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments
Rehan M. Hussain, MD
Annual Meeting Talks
2021
Long-term Experience With Intravitreal Anti-VEGF Treatment in Patients With nAMD: Analysis of IRIS® (Intelligent Research in Sight) Registry Database
Theodore Leng, MD, MS, FASRS
Annual Meeting Talks
2021
Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies
Chirag D. Jhaveri, MD, FASRS
On Demand Cases, Courses, and Papers
2020
Intravitreal AAVCAGsCD59 as Adjunct Anti-VEGF Treatment for Wet Age-Related Macular Degeneration
Jeffrey S. Heier, MD
Annual Meeting Talks
2020
Comparative Efficacy of Different Anti-VEGF Treatment Regimens in Patients With nAMD: A Network Meta-Analysis
Diana V Do, MD, FASRS
Annual Meeting Talks
2020
Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy
Alay S. Banker, MD
Annual Meeting Talks
2020
Tricks of Anti-VEGF Treatment for Retinopathy of Prematurity: How and when to Do It? When to Wait? When to Redo?
HUSEYIN YETIK, MD, PROFESSOR OF OPHTHALMOLGY
On Demand Cases, Courses, and Papers
2019